Fertility Supplements Market Size, Share, Growth Analysis, By End-Use(Men, and Women), By Distribution Channel(OTC, and Prescribed) - Industry Forecast 2024-2031

North America held the largest share in the global fertility supplements market. Data from the Centers for Disease Control and Prevention (CDC) update indicated that 14.1% of women aged 15 to 49 in the U.S. had impaired fertility, while 15.1% of married women aged 15 to 49 had impaired fertility. In addition, 7% of married women were found to be infertile, which has increased the demand for fertility products in the region. Furthermore, the market in Canada is expected to grow rapidly due to initiatives by the government and nonprofit organizations such as Fertility Matters Canada to raise awareness about fertility medication and treatment, as well as the rising rates of obesity and sexually transmitted infections.

Asia Pacific is expected to experience significant growth in the fertility supplement market, with a projected CAGR of 12.0% from 2022 to 2030. The region offers promising opportunities for leading companies due to increased accessibility and availability of healthcare facilities, as well as increased expenditure in the research and healthcare sectors. Rising awareness about nutritional enrichment in India and China is expected to be a significant factor for regional growth. Additionally, the retail market is expected to expand in countries such as India, China, Indonesia, and Malaysia due to regulatory support to encourage investment, which will increase buyer accessibility and help the market grow in the region.